Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
SPECIAL ANNOUNCEMENT
2016 Photonics Buyers' Guide Clearance! – Use Coupon Code FC16 to save 60%!
share
Email Facebook Twitter Google+ LinkedIn Comments

University of Rochester in New York

BioPhotonics
May 2011
A technology that has helped improve eyesight is now more widely available, thanks to approval by the FDA. Created by physicians and scientists at the University of Rochester in New York, the Rochester Nomogram marks an advance for patients who undergo lasik surgery. A company that has licensed the technology from the university announced that the FDA has approved its use in its refractive surgery system. Technolas Perfect Vision GmbH of Munich, Germany, is a cataract and refractive laser company that was formed through a joint venture of Bausch + Lomb and 20/10 Perfect Vision AG. It offers the Nomogram technology in its refractive surgery correction system. The Nomogram adjusts the way a laser interacts with a person’s vision, reducing the chances that the eyes will be near- or farsighted after the procedure. Patients at the Flaum Eye Institute in Rochester have benefited from the research.


Comments
Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2016 Photonics Media
x Subscribe to BioPhotonics magazine - FREE!